UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 9, 2023 4:30 P.M.
Form:
F-1
CIK:
0001601936
Company Name:
Altamira Therapeutics Ltd.
File Number:
333-272336